Do heat shock proteins have a role in breast cancer?

British Journal of Cancer

Volumn 74, Issue 5, 1996, Pages 717-721

  Conroy, S E ^a   Latchman, D S ^a  

^a Medical Molecular Biology Unit   (United Kingdom)

Author keywords

Breast cancer; Heat shock protein; HSP27; HSP70; HSP90

Indexed keywords

HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90;

BREAST CANCER; HUMAN; IMMUNOTHERAPY; PRIORITY JOURNAL; REVIEW; SURVIVAL;

EID: 0029775839     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.427     Document Type: Review

References (51)

1. CIOCCA DR AND DUFAU ML. (1984). Estrogen-dependent Leydig cell protein recognised by monoclonal antibody to MCF-7 cell line. Science, 226, 445-446.
2. CIOCCA DR AND LUQUE EH. (1991). Immunological evidence for the identity between the hsp27 estrogen related heat shock protein and the p29 estrogen receptor in breast and endometrial cancer. Breast Cancer Res. Treat., 20, 33 42.
3. CIOCCA DR, ADAMS DJ, BJERCKE RJ, EDWARDS DP AND MCGUIRE WL. (1982). Immunohistochemical detection of an estrogen-regulated protein by monoclonal antibodies. Cancer Res., 42, 4256-4258.
4. CIOCCA DR, FUQUA SAW, LOCK-LIN S, TOFT DO, WELCH WJ AND MCGUIRE WL. (1992). Responses of human breast cancer cells to heat shock and chemotherapeutic drugs. Cancer Res., 52, 3648 3654.
5. CIOCCA DR, OESTERREICH S, CHAMNESS GC, MCGUIRE WL AND FUQUA SAW. (1993a). Biological and clinical implications of heat shock protein 27000 (Hsp27) A review. J. Natl Cancer Inst., 85, 1558-1570.
6. CIOCCA DR, CLARK GM, TANDON AK, FUQUA SAW, WELCH WJ AND MCGUIRE WL. (1993b). Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications. J. Natl Cancer Inst., 85, 570 574.
7. COFFER AI, LEWIS KM, BROCKAS AJ AND KING RJB. (1985). Monoclonal antibodies against a component related to a soluble estrogen receptor. Cancer Res., 45, 3686 3693.
8. CONROY SE, GIBSON SL, BRUNSTROM G, ISENBERG D, LUQMANI Y AND LATCHMAN DS. (1995). Autoantibodies to the 90kD heat shock protein in sera of breast cancer patients. Lancet, 345, 126 127.
9. CRAWFORD LV, PIM DC AND BULBROOK RD. (1982). Detection of antibodies against the cellular protein P53 in patients from sera with breast cancer. Int. J. Cancer, 30, 403 408.
10. CREIGHTON TE. (1990). Protein folding. Biochem J., 270, 1-16.
11. DAVIDOFF AM, IGLEHART JD AND MARKS JR. (1992). Immune response to P53 is dependent upon P53/hsp70 complexes in breast cancers. Proc. Natl Acad. Sci. USA, 89, 3439 3442.
12. EDWARDS DP, ADAMS DJ AND MCGUIRE WL. (1981). Estradiol stimulates synthesis of a major intracellular protein in breast cancer cell line (MCF-7). Breast Cancer Res. Treat., 1, 209 223.
13. FERRARINI M, HELTAI S, ZOCCHI MR AND RUGARLI C. (1992). Unusual expression and localization of heat shock proteins in human tumor cells. Int. J. Cancer, 51, 613 619.
14. FUQUA SAW, SALINGAROS MB AND MCGUIRE WL. (1989). Induction of the estrogen-regulated '24K' protein by heat shock. Cancer Res., 49, 4126 4129.
15. r 27,000 heat shock protein. Cancer Res., 51, 5245-5252.
16. IWAYA K, HITOSHI T, FUJITA S, SUZUKI M AND HIROHASHI S. (1995). Natural state of mutant P53 protein and hsp70 in breast cancer tissue. Lab. Invest., 72, 707-714.
17. JAMEEL A, SKILTON RA, CAMPBELL TA, CHANDLER SK, COOMBES RC AND LUQMANI YA. (1992). Clinical and biological significance of HSP90 alpha in human breast cancer. Int. J. Cancer, 50, 409-415.
18. JAMEEL A, LAW M, COOMBES RC AND LUQMANI Y. (1993). Significance of heat shock protein 90 as a prognostic indicator in breast cancer. Int. J. Oncol., 2, 1075 1080.
19. KONNO A, SATO N, YAGIHASHI A, TORIGOE T, CHO J, TORIMOTO K, HARA I, WADA Y, OKUBO M, TAKAHASHI AND KIKUCHI K. (1989). Heat or stress inducible transformation-associated cell surface antigen on the activated H-ras oncogene-transfected rat fibroblast. Cancer Res., 49, 6578 6582.
20. LATCHMAN DS. (1991). Heat shock proteins and human disease. J. R. Coll. Physicians, 25, 295-299.
21. LINDQUIST S. (1986). The heat shock response. Annu. Rev. Biochem., 55, 1151 1191.
22. LINDQUIST S AND CRAIG FA. (1988). The heat shock proteins. Annu. Rev. Genet., 22, 631-677.
23. LOVE S AND KING RJB. (1994). A 27 kDa heat shock protein that has anomalous prognostic powers in early and advanced breast cancer. Br. J. Cancer. 69, 743-748.
24. LUKACS KV, LOWRIE DB, STOKES RW AND COLSTON MJ. (1993). Tumor cells transfected with a bacterial heat shock gene lose tumorigenicity and induce protection against tumours. J. Exp. Med., 178(1), 343-348.
25. MILEO AM, FANUELE M, BATTAGLIA F , SCAMBIA G, BENEDETTI-PANICI P, MANCUSO S AND FERRINI U. (1990). Selective over-expression of mRNA coding for 90 KDa stress-protein in human ovarian cancer. Anticancer Res., 10, 903 906.
26. MIRON T, VAN COMPERNOLLE K, VAN DE KERCHOVE J, WILCHEK M AND GEIGER B. (1991). A 25 kD inhibitor of actin polymerisation is a low molecular mass heat shock protein. J. Cell. Biol. 114(2), 255 261.
27. MULTHOFF G, BOTZLER C, WIESNET M, MALLER E, MEIER T AND WILMANNS W. (1995). A stress-inducible 72-kDa heat shock protein (hsp72) is expressed on the surface of human tumors but not on normal cells. Int. J. Cancer, 61, 272 279.
28. NANBU K, KONSHI I, KOMATSU T, MANDAI M, YAMAMOTO S, KURODA H, KOSHIYAMA M AND MORI T. (1996). Expression of heat shock proteins HSP70 and HSP90 in endometrial carcinomas. Cancer, 77, 330 338.
29. OESTERREICH S, WENG C-N, QIU M, HILSENBECK SG, OSBOURNE CK AND FUQUA SAW. (1993). The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines. Cancer Res., 53, 4443 4448.
30. PINHASI-KIMHI O, MICHALOVITZ D, BEN-ZEEV A AND OREN M. (1986). Specific interactions between the p53 cellular tumour antigen and major heat shock proteins. Nature, 320, 182-185.
31. PRATT WB. (1987). Transformation of glucocorticoid receptor and progesterone receptor to the DNA-binding state. J. Cell. Biochem, 35, 51 68.
32. RITOSSA F. (1962). A new puffing pattern induced by temperature, shock and DNP in Drosophila. Experientia, 18, 571 573.
33. SEYMOUR L, BEZWODA WR AND MEYER K. (1990). Tumour factors predicting for prognosis in metastatic breast cancer. The presence of p24 predicts for response to treatment and duration of survival. Cancer, 66, 2390 2394.
34. SHYAMALA G, GAUTHIER Y, MOORE SK, CATELLI MG AND ULLRICH SJ. (1989). Estrogenic regulation of murine uterine 90-Kilodalton heat shock protein expression. Mol. Cell. Biol., 9, 3567 3570.
35. SRIVASTAVA PK. (1994). Peptide binding heat shock protein in the endoplasmic reticulum. Role in immune response to cancer and in antigen presentation. Adv. Cancer Res., 62, 153 177.
36. SRIVASTAVA PK, DE LEO AB AND OLD LJ. (1986). Tumour rejection antigens of chemically induced sarcomas of inbred mice. Proc. Natl Acad. Sci. USA, 83, 3407-3411.
37. SRIVASTAVA PK AND OLD LJ. (1988). Individually distinct transplantation antigens of chemically induced mouse tumours. Immunol. Today, 9, 78-83.
38. SRIVASTAVA PK AND HEIKE M. (1991). Tumor specific immunogenicity of stress induced proteins: Convergence of two evolutionary pathways of antigen presentation. Semin. Immunol., 3, 57 66.
39. SRIVASTAVA PK, UDONO H, BLACHERE E AND LI Z. (1994). Heat shock protein transfer peptides during antigen processing and CTL priming. Immunogenetics, 39, 93-98.
40. TANDON AK, CLARK GM, CHAMNES GC, FUQUA SAW, WELCH WJ, RIEHL RM AND MCGUIRE WL. (1991). Heat shock/stress response proteins: biological and clinical significance in breast cancer. Proc. Am. Soc. Clin. Oncol., 9, 23.
41. TETU B, LACASSE B, BOUCHARD H-L, LAGACE R, HUOT J AND LAUDRY J. (1992). Prognostic influence of HSP27 expression in malignant fibrous histocytoma: A clinicopathological and immunohistochemical study. Cancer Res., 52, 2325-2328.
42. THIELE CJ, REYNOLDS CP AND ISRAEL MA. (1985). Decreased expression of N-myc precedes retinopic acid induced morphological differentiation of human neuroblastoma. Nature, 313, 404 406.
43. THOR A, BENZ C, MOORE D, GOLDMAN E, EDGERTON S, LANDRY J, SCHWARTZ L, MAYALL B, HICKEY E AND WEBER LA. (1991). Stress response protein (srp-27) determination in primary human breast carcinomas: clinical, histologic, and prognostic correlations. J. Natl Cancer Inst.. 83, 154-155.
44. TISSIERES A, MITCHELL HK AND TRACEY UM. (1974). Protein synthesis in salivary glands of D. melanogaster. Relation to chromosome puffs. J. Mol. Biol., 84, 389-398.
45. TSUBOI N, ISHIKAWA M, TAMURA Y, TAKAYAMA S, TOBIOKA H, MATSUURA A, HIRAYOSHI K, NAGATA K, SATO N AND KIKUCHI K. (1994). Monoclonal antibody specifically reacting against 73-kilodalton heat shock cognate protein: possible expression on mammalian cell surface. Hybridoma, 13, 373-381.
46. UDONO H AND SRIVASTAVA PK. (1993). Heat shock protein 70-associated peptides elicit specific cancer immunity. J. Exp. Med., 178, 1391-1396.
47. ULLRICH SJ, ROBINSON EA, LAIN LW, WILLINGHAM M AND APPELLA E. (1986). A mouse tumor specific transplantation antigen is a heat shock related protein. Proc. Natl Acad. Sci. USA, 83, 3121-3125.
48. UNGAR DR, HAILAT N, STRAHLER JR, KUICK RD, GARRETT MB, SEEGER RC, REYNOLDS CP AND HANASH SM. (1994). Hsp27 expression in neuroblastoma: correlation with disease stage. J. Natl Cancer Inst., 86, 780-784.
49. VAN BUSKIRK A, CRUMP BL, MARGOLIASH E AND PIERCE SK (1989). A peptide binding protein having a role in antigen presentation is a member of the hsp70 gene family. J. Exp. Med., 170 (6) 1968-1970.
50. VOJTESEK B, KOVARIK J, DOLEZALOVA H, NENUTIL R, HAVLIS P, BRENTANI RR AND LANE DP. (1995). Absence of P53 autoantibodies in a significant proportion of breast cancer patients. Br. J. Cancer, 71, 1253-1256.
51. + T cells react to B cell lines expressing heat shock protein 70. J. Immunol., 153, 4149-4158.